Under construction – not a live service
Sign in
Taking people in FinlandNo phase

Digital care pathway and messaging with a nurse for uncontrolled high blood pressure

Tests digital care and nurse messaging in adults with high blood pressure.

Plain-language title generated from the registry record
Registry title: Effectiveness and Cost-Effectiveness of a Digital Care Pathway and Asynchronous Communication for Patients With Hypertension

Key facts

Where
Akaa, Sastamala, Tampere, and Valkeakoski, FinlandSee the 6 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 30 and 74 years old?

Source: NCT07812350, who can take part

Where in Finland

  • Akaa health and social services centre, The Wellbeing Services County of PirkanmaaAkaa, FinlandTaking people
  • Sastamala health and social services centre, The Wellbeing Services County of PirkanmaaSastamala, FinlandTaking people
  • Hatanpää health and social services centre, The Wellbeing Services County of PirkanmaaTampere, FinlandTaking people
  • Hervanta health and social services centre, The Wellbeing Services County of PirkanmaaTampere, FinlandTaking people
  • Linnainmaa health and social services centre, The Wellbeing Services County of PirkanmaaTampere, FinlandTaking people
  • Valkeakoski health and social services centre, The Wellbeing Services County of PirkanmaaValkeakoski, FinlandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Wellbeing Services County of Pirkanmaa
Trial code
NCT07812350
Record updated
21 October 2026
Original description
The goal of this clinical trial is to learn if digital care pathway (DCP) and digital non-real-time messaging, in other words, asynchronous communication (AC) with nurse works to treat high blood pressure in adults in primary care. It will also learn if DCP and AC are good value for money. The main questions it aims to answer are:Read full original descriptionShow less

Digital Care Pathway and Asynchronous Communication for Primary Care Patients With Uncontrolled Hypertension: a Cluster-Randomized Controlled Trial

The goal of this clinical trial is to learn if digital care pathway (DCP) and digital non-real-time messaging, in other words, asynchronous communication (AC) with nurse works to treat high blood pressure in adults in primary care. It will also learn if DCP and AC are good value for money. The main questions it aims to answer are:

* Does DCP and AC lower systolic blood pressure? * Are DCP and AC good value for money in treating high blood pressure? Researchers will compare usual care plus DCP and usual care plus DCP with AC to usual care only to see if DCP and AC works to treat high blood pressure.

Participants will:

* Get usual care or usual care plus DCP or usual care plus DCP with AC for 6 months * Visit the study nurse at the start of the trial and after 6 months for checkup and tests which include usual laboratory tests for high blood pressure * Answer online survey questions and measure their blood pressure at home for 4 days at the start of the trial and after 6 months

Inclusion: a diagnosis of hypertension for at least 3 months; an office blood pressure of ≥140/90 mmHg at baseline; access to a smartphone and the ability to use strong electronic identification for application login; ability to measure home blood pressure; ability to take care of the personal medication.

Exclusion: secondary hypertension or hypertensive crisis (office blood pressure >200/130 mmHg); a clearly impaired ability to use the study interventions or participate in the study, as determined by a healthcare professional (e.g., insufficient Finnish language proficiency, dementia, psychiatric illness, or sensory impairments); stage 4 or 5 chronic kidney disease (eGFR <30 mL/min/1.73 m²); unwillingness to participate in the study; atrial fibrillation; a life expectancy of less than 1 year; pregnancy or breastfeeding.

ClinicalTrials.gov NCT07812350